Ignite Creation Date:
2025-12-24 @ 11:16 PM
Ignite Modification Date:
2026-01-17 @ 9:11 AM
Study NCT ID:
NCT04106856
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-04-06
First Post:
2019-09-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Losartan and Hypofractionated Rx After Chemo for Tx of Borderline Resectable or Locally Advanced Unresectable Pancreatic Cancer (SHAPER)
Sponsor:
University of Utah
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-08-08
Start Date Type:
ACTUAL
Primary Completion Date:
2024-12-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-08-08
Completion Date Type:
ESTIMATED
First Submit Date:
2019-09-25
First Submit QC Date:
None
Study First Post Date:
2019-09-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-04-03
Last Update Post Date:
2025-04-06
Last Update Post Date Type:
ACTUAL